View More View Less
  • 1 University of Kaposvár Department of Physiology, Faculty of Animal Science Kaposvár Hungary
  • | 2 H-1071 Budapest Dózsa Gy. út 64 Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The effect of pre-treatment with Escherichia coli O83 lipopolysaccharide (LPS) on concanavalin A-induced ascites was examined. The LPS was injected intraperitoneally (i.p.) in different doses to mice, and then ascites was induced by i.p. administration of concanavalin A (ConA) (25 mg/kg b.w.). After 2.5 h the mice were killed and the ascitic fluid was collected and measured. The LPS produced a marked and dose-dependent inhibition of ConA-induced ascites and the effect of pre-treatment lasted up to almost a week. Complete inhibition could not be achieved. If administered alone, LPS did not produce ascites.It is well known that LPS enhances vascular permeability in several tissues, but the present work shows that peritoneal permeability is not enhanced by this agent. Suppression of ConA-induces ascites may be explained by the hypotonic effect of LPS.

  • Baintner, K.: Inflammatory ascites formation induced by macromolecules in mice and rats. Am J Physiol Regul Integr Comp Physiol 296, R218–R223 (2009).

    Baintner K. , 'Inflammatory ascites formation induced by macromolecules in mice and rats ' (2009 ) 296 Am J Physiol Regul Integr Comp Physiol : R218 -R223.

    • Search Google Scholar
  • Westphal, O., Jann, K.: Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 5, 83–91 (1965).

    Jann K. , 'Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure ' (1965 ) 5 Methods Carbohydr Chem : 83 -91.

    • Search Google Scholar
  • Roth, J.: Ultrahistochemical demonstration of saccharide components of complex carbohydrates at the alveolar cell surface and at the mesothelial cell surface of the pleura visceralis of mice by means of concanavalin A. Exp Pathol (Jena) 8, 157–167 (1973).

    Roth J. , 'Ultrahistochemical demonstration of saccharide components of complex carbohydrates at the alveolar cell surface and at the mesothelial cell surface of the pleura visceralis of mice by means of concanavalin A ' (1973 ) 8 Exp Pathol (Jena) : 157 -167.

    • Search Google Scholar
  • Baintner, K., Bodnár, Zs., Kiss, P., L. Kiss, A., Lukáts, Á.: Effect of intraperitoneally administered plant lectins on leukocyte diapedesis and visceral organ weight in rats and mice. Pathol Oncol Res 13, 139–143 (2007).

    Lukáts , 'Effect of intraperitoneally administered plant lectins on leukocyte diapedesis and visceral organ weight in rats and mice ' (2007 ) 13 Pathol Oncol Res : 139 -143.

    • Search Google Scholar
  • Baintner, K., Kocsis, B., Kovács, K., Péterfi, Z., Kökény, G., Hamar, P.: Interaction of concanavalin A with bacterial lipopolysaccharides in agarose gel. Acta Microbiol Immunol Hung 58, 201–209 (2011).

    Hamar P. , 'Interaction of concanavalin A with bacterial lipopolysaccharides in agarose gel ' (2011 ) 58 Acta Microbiol Immunol Hung : 201 -209.

    • Search Google Scholar
  • Flessner, M. F.: The transport barrier in intraperitoneal therapy. Am J Renal Physiol 288, F433–F442 (2005).

    Flessner M. F. , 'The transport barrier in intraperitoneal therapy ' (2005 ) 288 Am J Renal Physiol : F433 -F442.

    • Search Google Scholar
  • Flessner, M. F.: Endothelial glycocalyx and the peritoneal barrier. Perit Dial Int 28, 6–12 (2008).

    Flessner M. F. , 'Endothelial glycocalyx and the peritoneal barrier ' (2008 ) 28 Perit Dial Int : 6 -12.

    • Search Google Scholar
  • Boutten, A., Dehoux, M., Deschenes, M., Rouzeau, J. D., Bories, P. N., Durand, G.: Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol 22, 2687–2695 (1992).

    Durand G. , 'Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages ' (1992 ) 22 Eur J Immunol : 2687 -2695.

    • Search Google Scholar
  • Sodhi, A., Kesherwani, V.: Signaling molecules involved in production and regulation of IL-1beta by murine peritoneal macrophages in vitro on treatment with concanavalin A. Int Immunopharmacol 7, 1403–1413 (2007).

    Kesherwani V. , 'Signaling molecules involved in production and regulation of IL-1beta by murine peritoneal macrophages in vitro on treatment with concanavalin A ' (2007 ) 7 Int Immunopharmacol : 1403 -1413.

    • Search Google Scholar
  • Guruvayoorappan, C., Kuttan, G.: Rutin inhibits nitric oxide and tumor necrosis factor-alpha production in lipopolysaccharide and concanavalin-a stimulated macrophages. Drug Metabol Drug Interact 22, 263–278 (2007).

    Kuttan G. , 'Rutin inhibits nitric oxide and tumor necrosis factor-alpha production in lipopolysaccharide and concanavalin-a stimulated macrophages ' (2007 ) 22 Drug Metabol Drug Interact : 263 -278.

    • Search Google Scholar
  • Yi, E. S., Ulich, T. R.: Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules. Am J Pathol 140, 659–663 (1992).

    Ulich T. R. , 'Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules ' (1992 ) 140 Am J Pathol : 659 -663.

    • Search Google Scholar
  • McCuskey, R. S., Urbaschek, R., Urbaschek, B.: The microcirculation during endotoxemia. Cardiovasc Res 32, 752–763 (1996).

    Urbaschek B. , 'The microcirculation during endotoxemia ' (1996 ) 32 Cardiovasc Res : 752 -763.

    • Search Google Scholar
  • Bannerman, D. D., Goldblum, S. E.: Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am J Physiol 273, L217–L226 (1997).

    Goldblum S. E. , 'Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation ' (1997 ) 273 Am J Physiol : L217 -L226.

    • Search Google Scholar
  • Baluna, R., Vitetta, E. S.: Vascular leak syndrome: A side effect of immunotherapy. Immunopharmacology 37, 117–132 (1997).

    Vitetta E. S. , 'Vascular leak syndrome: A side effect of immunotherapy ' (1997 ) 37 Immunopharmacology : 117 -132.

    • Search Google Scholar
  • Holbeck, S., Grande, P. O.: Endotoxin increases both protein and fluid microvascular permeability in cat skeletal muscle. Crit Care Med 31, 560–565 (2003).

    Grande P. O. , 'Endotoxin increases both protein and fluid microvascular permeability in cat skeletal muscle ' (2003 ) 31 Crit Care Med : 560 -565.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 9 0 0
Mar 2021 16 0 0
Apr 2021 0 0 0
May 2021 7 0 0
Jun 2021 0 0 0
Jul 2021 2 0 0
Aug 2021 0 0 0